Biallelic expression of the IGF2 gene in human breast disease

Human Molecular Genetics

Volumn 5, Issue 8, 1996, Pages 1123-1127

  McCann, Amanda H ^a   Miller, Nicola ^a   O'Meara, Anne ^b   Pedersen, Inge ^a   Keogh, Karina ^a   Gorey, Thomas ^a   Dervan, Peter A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; BREAST LESION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0029797635     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.8.1123     Document Type: Article

References (42)

1. Leong, A. S.-Y. and Lee, A.K.C. (1995) Biological indices in the assessment of breast cancer. J. Clin. Pathol: Mol. Pathol. 48, M221-M238.
2. Giannoukakis, N., Deal, C., Raquette, J., Goodyer, C.G. and Polychronakos, C. (1993) Parental genomic imprinting of the human ICF2 gene. Nature Genet., 4, 98-101.
3. Ohlsson, R., Nyström, A., Pfeifer-Ohlsson, S., Töhönen, V., Hedborg, F, Schofield, P., Flam, F. and Ekström, T.J. (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith Weidemann Syndrome. Nature Genet., 4, 94-97.
4. Efstratiadis, A. (1994) Parental imprinting of autosomal mammalian genes. Curr. Opin. Genet. Dev., 4, 265-280.
5. Davies, S.M. (1994) Developmental regulation of genomic imprinting of the 1GF2 gene in human liver. Cancer Res., 54, 2560-2562.
6. Ohlsson, R., Hedborg, F., Holmgren, L., Walsh, C. and Ekström, T.J. (1994) Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression Development, 120, 361-368.
7. Feinberg, A.P. (1993) Genomic imprinting and gene activation in cancer. Nature Genet., 4, 110-113.
8. Little, M. and Wainwright, B. (1995) Methylation and p16: suppressing the suppressor. Nature Med., 1, 633-664.
9. Merlo, A., Herman, J.G., Mao L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
10. Knudson, A.G. and Strong, L.C. (1971) Mutation and cancer: statistical study of retinoblastoma. Pm: Natl Acad. Sci. USA, 68, 820-823.
11. Herman, J.G., Sakai, T., Togauchida, J., Ohtani, N., Yandell, D.W., Rapaport, J.M. and Dryja, T.P. (1994) Silencing of the VHL tumour suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA. 91, 9700-9704.
12. Sakai, T. Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R. and Linehan, W.M. (1991) Allele-specific hypermethylation of the retinoblastoma tumour suppressor gene. Am. J. Hum. Genet., 48, 880-888.
13. Weksberg, R., Shen, D.R., Fei, V.L. Song, Q.L. and Squire, J. (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet., 5, 143-149.
14. Rainier, S., Johnson, L.A., Dobry, C.J., Ping, AJ., Grundy, P.E. and Feinberg, A.P. (1993) Relaxation of imprinted genes in human cancer. Nature. 362, 747-749.
15. Ogawa, O., Eccles, M.R., Szeto. J., McNoe, L.A., Yun, K., Maw, M.A., Smith, PJ. and Reeve, A.E. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilm's tumour. Nature. 362, 749-751.
16. Zhan, S., Shapiro, D.N. and Helman, L.J. (1994) Activation of an imprinted allele of the insulin-like growth factor II gene implicated in Rhabdomyosarcoma. J. Clin. Invest., 94, 445-448.
17. Pedone, P.V., Tirabosco, R., Cavazzana, A.O., Ungaro, P., Basso, G., Luksch, R., Carli, M., Bruni, C.B., Frunzio, R. and Riccio, A. (1994) Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum. Mol. Genet., 3, 1117-1121.
18. Rainier, S., Dobry, C.J. and Feinberg, A.P. (1995) Loss of imprinting in hepatoblastoma. Cancer Res., 55, 1836-1838.
19. Li, X., Adam, G., Cui, H., Sandstedt, B., Ohlsson, R. and Ekström, T.J. (1995) Expression, promoter usage and parental imprinting status of insulin-like growth factor(IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene, 11, 221-229.
20. van Gurp, R.J., Oosterhuis, J.W., Kalscheuer, V., Mariman, E.C. and Looijenga, L.H. (1994) Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumours. J Natl Cancer Inst., 86, 1070-1075.
21. Hashimoto, K., Azuma, C., Koyama, M., Ohashi, K., Kamiura, S., Nobunaga, T., Kimura, T., Tokugawa, Y., Kanai, T. and Saji, F. (1995) Loss of imprinting in choriocarcinoma. Nature Genet., 9, 109-110.
22. Suzuki, H., Ueda, R., Takahashi, T. and Takahashi, T. (1994) Altered imprinting in lung cancer. Nature Genet., 6, 332-333.
23. Douc-Rassy, S., Barrois, M., Fogel, S., Ahomadegbe, J.C., Stehelin, D., Coll, J. and Riou, G. (1996) High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene, 12, 423-430.
24. Hedborg, F., Holmgren, L., Sandstedt, B. and Ohlsson, R. (1994) The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann Syndrome. Am. J. Pathol., 145, 802-817.
25. Yee, D., Cullen, K.J., Paik, S., Perdue, J.F., Hampton, B., Schwartz, A., Lippman, M.E. and Rosen, N. (1988) Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res., 48, 6691-6696.
26. Schneid, H., Seurin, D., Noguiez, P. and LeBouc, Y. (1992) Abnormalities of insulin-like growth factor (IGF-I and IGF-II) genes in human tumour tissue. Growth Regul., 2, 45-54.
27. Tadokoro, K., Fujii, H., Inoue, T. and Yamada, M. (1991) Polymerase chain reaction (PCR) for detection of an ApaI polymorphism at the insulin-like growth factor II gene (IGF2). Nucleic Acids Res., 19, 6967.
28. Christofori, G., Naik, P. and Hanahan, D. (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumourigenesis. Nature, 369, 414-418.
29. Christofori, G., Naik, P. and Hanahan, D. (1995) Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumourigenesis. Nature Genet., 10, 196-201.
30. Davies, S.M. (1993) Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res., 53, 4781-4783.
31. Jinno, Y., Yun, K., Nishiwaki, K., Kubota, T., Ogawa, O., Reeve, A.E. and Niikawa, N. (1994) Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet., 6, 305-309.
32. Drummond, I.A., Madden, S.L., Rohwer-Nutter, P., Bell, G.I., Sukhatme, V.P. and Rauscher, J.F. (1992) Repression of the insulin-like growth factor II gene by the Wilms' tumour suppressor WT1. Science, 257, 674-678.
33. Cullen, K.J., Smith, H.S., Hill, S., Rosen, N. and Lippman, M.E. (1991) Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res., 51, 4978-4985.
34. Evan, G.I., Wyllie, A.H., Gilberts, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128 .
35. Page, D.L., Dupont, W.D. and Rogers, L.W. (1988) Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum. Pathol., 19, 201-207.
36. Winqvist, R., Mannermaa, A., Alavaikko, M., Blanco, G., Taskinen, P.J., Kiviniemi, H., Newsham, I. and Cavenee, W. (1993) Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumours. Cancer Res., 53, 4486-4488.
37. Zhang, Y. and Tycko, B. (1992) Monoallelic expression of the human H19 gene. Nature Genet., 1, 40-44.
38. Hao, Y. Crenshaw, T. Moulton, T. Mewcomb, E. and Tycko, B. (1993) Tumour-suppressor activity of H19 RNA. Nature, 365, 764-767.
39. Haig, D. and Graham, C. (1991) Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell, 64, 1045-1046.
40. Xu, Y., Goodyer, C.G., Deal, C. and Polychronakos, C. (1993) Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun., 2, 747-754.
41. Bates, P., Fisher, R., Ward, A., Richardson, L., Hill, D.J. and Graham, C.F. (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) Br. J. Cancer, 72, 1189-1183.
42. Bloom, H.J.C. and Richardson, W.W. (1957) Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years Br. J. Cancer, 11, 359-377.